• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHB0601418 甘草酸单钾盐片 Tablet Chemical Drugs Supplementary Application 2006-11-07 山东山大康诺制药有限公司 Shandong Shanda Kangnuo Pharmaceutical Co Ltd Certificate Issued 2008-05-07 view
CYHB0600988 去甲斑蝥素片 norcantharidin Tablet Chemical Drugs Supplementary Application 2006-11-06 山东山大康诺制药有限公司 Shandong Shanda Kangnuo Pharmaceutical Co Ltd Certificate Issued 2007-10-24 view
CYHB0601860 羟甲烟胺 Nicotinylmethylamide Active ingredient Chemical Drugs Supplementary Application 2006-11-06 山东山大康诺制药有限公司 Shandong Shanda Kangnuo Pharmaceutical Co Ltd Certificate Issued 2007-05-08 view
CYHB0601861 羟甲烟胺片 Nicotinylmethylamide Tablet Chemical Drugs Supplementary Application 2006-11-06 山东山大康诺制药有限公司 Shandong Shanda Kangnuo Pharmaceutical Co Ltd Certificate Issued 2007-08-24 view
CXHL0501394 盐酸美金刚 memantine hydrochloride Active ingredient Chemical Drugs(3.1) New Drug Application 2005-09-01 山东山大康诺制药有限公司 Shandong Shanda Kangnuo Pharmaceutical Co Ltd Certificate Issued 2006-06-28 view
CXHL0501395 盐酸美金刚片 memantine hydrochloride Tablet Chemical Drugs(3.1) New Drug Application 2005-09-01 山东山大康诺制药有限公司 Shandong Shanda Kangnuo Pharmaceutical Co Ltd Certificate Issued 2006-06-28 view
X0405139 普卢利沙星胶囊 prulifloxacin Capsule Chemical Drugs(3.1) New Drug Application 2004-09-13 山东山大康诺制药有限公司 Shandong Shanda Kangnuo Pharmaceutical Co Ltd Certificate Issued 2005-08-26 view
X0405138 普卢利沙星 prulifloxacin Active ingredient Chemical Drugs(3.1) New Drug Application 2004-09-13 山东山大康诺制药有限公司 Shandong Shanda Kangnuo Pharmaceutical Co Ltd Certificate Issued 2005-08-26 view
X0405140 普卢利沙星片 prulifloxacin Tablet Chemical Drugs(3.1) New Drug Application 2004-09-13 山东山大康诺制药有限公司 Shandong Shanda Kangnuo Pharmaceutical Co Ltd Certificate Issued 2005-08-26 view